Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.

Saved in:
Bibliographic Details
Title: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Authors: Sprague SM; NorthShore University Health System, Evanston, Illinois.; University of Chicago Pritzker School of Medicine, Chicago, Illinois., Weiner DE; Tufts Medical Center, Boston, Massachusetts., Tietjen DP; Nephrology Consultants LLC, Huntsville, Alabama., Pergola PE; Renal Associates PA, San Antonio, Texas., Fishbane S; Zucker School of Medicine at Hofstra & Northwell Health, Great Neck, New York., Block GA; US Renal Care, Denver, Colorado., Silva AL; Boise Kidney and Hypertension Institute, Meridian, Idaho., Fadem SZ; Kidney Associates, PLLC and Baylor College of Medicine, Houston, Texas., Lynn RI; Kidney Medical Associates, Bronx, New York., Fadda G; Balboa Nephrology Medical Group, La Mesa, California., Pagliaro L; Ardelyx, Inc., Waltham, Massachusetts., Zhao S; Ardelyx, Inc., Waltham, Massachusetts., Edelstein S; Ardelyx, Inc., Waltham, Massachusetts., Spiegel DM; Ardelyx, Inc., Waltham, Massachusetts., Rosenbaum DP; Ardelyx, Inc., Waltham, Massachusetts.
Source: Kidney360 [Kidney360] 2024 May 01; Vol. 5 (5), pp. 732-742. Date of Electronic Publication: 2024 Feb 07.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 101766381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2641-7650 (Electronic) Linking ISSN: 26417650 NLM ISO Abbreviation: Kidney360 Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38323855
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sprague+SM%22">Sprague SM</searchLink>; NorthShore University Health System, Evanston, Illinois.; University of Chicago Pritzker School of Medicine, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Weiner+DE%22">Weiner DE</searchLink>; Tufts Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tietjen+DP%22">Tietjen DP</searchLink>; Nephrology Consultants LLC, Huntsville, Alabama.<br /><searchLink fieldCode="AU" term="%22Pergola+PE%22">Pergola PE</searchLink>; Renal Associates PA, San Antonio, Texas.<br /><searchLink fieldCode="AU" term="%22Fishbane+S%22">Fishbane S</searchLink>; Zucker School of Medicine at Hofstra & Northwell Health, Great Neck, New York.<br /><searchLink fieldCode="AU" term="%22Block+GA%22">Block GA</searchLink>; US Renal Care, Denver, Colorado.<br /><searchLink fieldCode="AU" term="%22Silva+AL%22">Silva AL</searchLink>; Boise Kidney and Hypertension Institute, Meridian, Idaho.<br /><searchLink fieldCode="AU" term="%22Fadem+SZ%22">Fadem SZ</searchLink>; Kidney Associates, PLLC and Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Lynn+RI%22">Lynn RI</searchLink>; Kidney Medical Associates, Bronx, New York.<br /><searchLink fieldCode="AU" term="%22Fadda+G%22">Fadda G</searchLink>; Balboa Nephrology Medical Group, La Mesa, California.<br /><searchLink fieldCode="AU" term="%22Pagliaro+L%22">Pagliaro L</searchLink>; Ardelyx, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zhao+S%22">Zhao S</searchLink>; Ardelyx, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Edelstein+S%22">Edelstein S</searchLink>; Ardelyx, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Spiegel+DM%22">Spiegel DM</searchLink>; Ardelyx, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Rosenbaum+DP%22">Rosenbaum DP</searchLink>; Ardelyx, Inc., Waltham, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101766381%22">Kidney360</searchLink> [Kidney360] 2024 May 01; Vol. 5 (5), pp. 732-742. <i>Date of Electronic Publication: </i>2024 Feb 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%2E+on+behalf+of+the+American+Society+of+Nephrology%22">Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101766381 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2641-7650 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226417650%22">26417650 </searchLink><i>NLM ISO Abbreviation: </i>Kidney360 <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38323855
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.34067/KID.0000000000000387
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 732
    Titles:
      – TitleFull: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sprague SM
      – PersonEntity:
          Name:
            NameFull: Weiner DE
      – PersonEntity:
          Name:
            NameFull: Tietjen DP
      – PersonEntity:
          Name:
            NameFull: Pergola PE
      – PersonEntity:
          Name:
            NameFull: Fishbane S
      – PersonEntity:
          Name:
            NameFull: Block GA
      – PersonEntity:
          Name:
            NameFull: Silva AL
      – PersonEntity:
          Name:
            NameFull: Fadem SZ
      – PersonEntity:
          Name:
            NameFull: Lynn RI
      – PersonEntity:
          Name:
            NameFull: Fadda G
      – PersonEntity:
          Name:
            NameFull: Pagliaro L
      – PersonEntity:
          Name:
            NameFull: Zhao S
      – PersonEntity:
          Name:
            NameFull: Edelstein S
      – PersonEntity:
          Name:
            NameFull: Spiegel DM
      – PersonEntity:
          Name:
            NameFull: Rosenbaum DP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2024 May 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2641-7650
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Kidney360
              Type: main
ResultId 1